Mesoblast Phase 3 Cell Therapy Trial for Chronic Low Back Pain Completes Enrollment Genetics Investing
Altimmune Announces Financial Results for the Year Ended December 31, 2017 and Provides Corporate Update Pharmaceutical Investing
Immunovaccine Announces Initiation of Patient Dosing in Investigator-Sponsored Phase 2 Clinical Trial Biotech Investing
3D Signatures Collaborates with MDxHealth to Evaluate Telo-PC™ Test in Prostate Cancer Pharmaceutical Investing
Krystal Submits Investigational New Drug Application for KB103 Topical Gene Therapy Candidate for Dystrophic Epidermolysis Bullosa Genetics Investing
Altimmune Announces Positive Data From Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine and Provides an Update Pharmaceutical Investing
Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials Pharmaceutical Investing
Loxo Oncology Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration Genetics Investing